Literature DB >> 29720570

RIPK3 mediates pathogenesis of experimental ventilator-induced lung injury.

Ilias I Siempos1,2, Kevin C Ma1, Mitsuru Imamura1, Rebecca M Baron3, Laura E Fredenburgh3, Jin-Won Huh4, Jong-Seok Moon1, Eli J Finkelsztein1, Daniel S Jones1, Michael Torres Lizardi5, Edward J Schenck1, Stefan W Ryter1, Kiichi Nakahira1, Augustine Mk Choi5.   

Abstract

In patients requiring ventilator support, mechanical ventilation (MV) may induce acute lung injury (ventilator-induced lung injury [VILI]). VILI is associated with substantial morbidity and mortality in mechanically ventilated patients with and without acute respiratory distress syndrome. At the cellular level, VILI induces necrotic cell death. However, the contribution of necroptosis, a programmed form of necrotic cell death regulated by receptor-interacting protein-3 kinase (RIPK3) and mixed-lineage kinase domain-like pseudokinase (MLKL), to the development of VILI remains unexplored. Here, we show that plasma levels of RIPK3, but not MLKL, were higher in patients with MV (i.e., those prone to VILI) than in patients without MV (i.e., those less likely to have VILI) in two large intensive care unit cohorts. In mice, RIPK3 deficiency, but not MLKL deficiency, ameliorated VILI. In both humans and mice, VILI was associated with impaired fatty acid oxidation (FAO), but in mice this association was not observed under conditions of RIPK3 deficiency. These findings suggest that FAO-dependent RIPK3 mediates pathogenesis of acute lung injury.

Entities:  

Keywords:  Fatty acid oxidation; Pulmonology

Year:  2018        PMID: 29720570      PMCID: PMC6012515          DOI: 10.1172/jci.insight.97102

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  45 in total

1.  Pretreatment with atorvastatin attenuates lung injury caused by high-stretch mechanical ventilation in an isolated rabbit lung model.

Authors:  Ilias I Siempos; Nikolaos A Maniatis; Petros Kopterides; Christina Magkou; Constantinos Glynos; Charis Roussos; Apostolos Armaganidis
Journal:  Crit Care Med       Date:  2010-05       Impact factor: 7.598

Review 2.  Approaches to the treatment of mitochondrial diseases.

Authors:  Salvatore DiMauro; Michio Hirano; Eric A Schon
Journal:  Muscle Nerve       Date:  2006-09       Impact factor: 3.217

3.  Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase.

Authors:  Liming Sun; Huayi Wang; Zhigao Wang; Sudan He; She Chen; Daohong Liao; Lai Wang; Jiacong Yan; Weilong Liu; Xiaoguang Lei; Xiaodong Wang
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

4.  CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis.

Authors:  Ting Zhang; Yan Zhang; Mingyao Cui; Li Jin; Yimei Wang; Fengxiang Lv; Yuli Liu; Wen Zheng; Haibao Shang; Jun Zhang; Mao Zhang; Hongkun Wu; Jiaojiao Guo; Xiuqin Zhang; Xinli Hu; Chun-Mei Cao; Rui-Ping Xiao
Journal:  Nat Med       Date:  2016-01-04       Impact factor: 53.440

5.  The death domain kinase RIP mediates the TNF-induced NF-kappaB signal.

Authors:  M A Kelliher; S Grimm; Y Ishida; F Kuo; B Z Stanger; P Leder
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

6.  The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis.

Authors:  Claudia Günther; Gui-Wei He; Andreas E Kremer; James M Murphy; Emma J Petrie; Kerstin Amann; Peter Vandenabeele; Andreas Linkermann; Christopher Poremba; Ulrike Schleicher; Christin Dewitz; Stefan Krautwald; Markus F Neurath; Christoph Becker; Stefan Wirtz
Journal:  J Clin Invest       Date:  2016-10-17       Impact factor: 14.808

7.  Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4.

Authors:  Kim Newton; Xiaoqing Sun; Vishva M Dixit
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

8.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

Review 9.  Emerging roles for lipids in non-apoptotic cell death.

Authors:  L Magtanong; P J Ko; S J Dixon
Journal:  Cell Death Differ       Date:  2016-03-11       Impact factor: 15.828

10.  Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment.

Authors:  Leong Lee; Ross Campbell; Michaela Scheuermann-Freestone; Rachel Taylor; Prasad Gunaruwan; Lynne Williams; Houman Ashrafian; John Horowitz; Alan G Fraser; Kieran Clarke; Michael Frenneaux
Journal:  Circulation       Date:  2005-11-22       Impact factor: 29.690

View more
  25 in total

Review 1.  Collateral damage: necroptosis in the development of lung injury.

Authors:  Hilary Faust; Nilam S Mangalmurti
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-27       Impact factor: 5.464

2.  Fatty acid synthase downregulation contributes to acute lung injury in murine diet-induced obesity.

Authors:  Maria Plataki; LiChao Fan; Elizabeth Sanchez; Ziling Huang; Lisa K Torres; Mitsuru Imamura; Yizhang Zhu; David E Cohen; Suzanne M Cloonan; Augustine Mk Choi
Journal:  JCI Insight       Date:  2019-07-09

3.  Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis.

Authors:  Edward J Schenck; Kevin C Ma; David R Price; Thomas Nicholson; Clara Oromendia; Eliza Rose Gentzler; Elizabeth Sanchez; Rebecca M Baron; Laura E Fredenburgh; Jin-Won Huh; Ilias I Siempos; Augustine Mk Choi
Journal:  JCI Insight       Date:  2019-05-02

Review 4.  Necroptosis: a crucial pathogenic mediator of human disease.

Authors:  Mary E Choi; David R Price; Stefan W Ryter; Augustine M K Choi
Journal:  JCI Insight       Date:  2019-08-08

5.  Circulating RIPK3 levels are associated with mortality and organ failure during critical illness.

Authors:  Kevin C Ma; Edward J Schenck; Ilias I Siempos; Suzanne M Cloonan; Eli J Finkelsztein; Maria A Pabon; Clara Oromendia; Karla V Ballman; Rebecca M Baron; Laura E Fredenburgh; Angelica Higuera; Jin Young Lee; Chi Ryang Chung; Kyeongman Jeon; Jeong Hoon Yang; Judie A Howrylak; Jin-Won Huh; Gee Young Suh; Augustine Mk Choi
Journal:  JCI Insight       Date:  2018-07-12

6.  JAK2/STAT1-mediated HMGB1 translocation increases inflammation and cell death in a ventilator-induced lung injury model.

Authors:  Qing Liu; Wanli Xie; Yanting Wang; Shiqiang Chen; Jingjing Han; Lei Wang; Ping Gui; Qingping Wu
Journal:  Lab Invest       Date:  2019-08-29       Impact factor: 5.662

7.  Effect of Neutropenic Critical Illness on Development and Prognosis of Acute Respiratory Distress Syndrome.

Authors:  David R Price; Katherine L Hoffman; Clara Oromendia; Lisa K Torres; Edward J Schenck; Mary E Choi; Augustine M K Choi; Rebecca M Baron; Jin-Won Huh; Ilias I Siempos
Journal:  Am J Respir Crit Care Med       Date:  2021-02-15       Impact factor: 21.405

Review 8.  Pulmonary Macrophage Cell Death in Lung Health and Disease.

Authors:  Abigail M Shotland; Andrew P Fontenot; Amy S McKee
Journal:  Am J Respir Cell Mol Biol       Date:  2021-05       Impact factor: 6.914

Review 9.  Integrating molecular pathogenesis and clinical translation in sepsis-induced acute respiratory distress syndrome.

Authors:  Joshua A Englert; Christopher Bobba; Rebecca M Baron
Journal:  JCI Insight       Date:  2019-01-24

Review 10.  The Role of the Key Effector of Necroptotic Cell Death, MLKL, in Mouse Models of Disease.

Authors:  Emma C Tovey Crutchfield; Sarah E Garnish; Joanne M Hildebrand
Journal:  Biomolecules       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.